TCT-499 Prognostic Implications of Pre-procedural TIMI Flow in Patients with STEMI Undergoing PCI with Drug-Eluting Stent Implantation
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.1675
Abstract: The negative prognostic effects of reduced pre-procedural Thrombolysis in Myocardial Infarction (TIMI) flow have been previously described in pts with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) with balloon angioplasty and bare… read more here.
Keywords: pre procedural; tct 499; timi flow; stemi undergoing ... See more keywords
Antithrombotic therapy for patients with STEMI undergoing primary PCI
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Cardiology"
DOI: 10.1038/nrcardio.2017.18
Abstract: Antithrombotic therapy, including antiplatelet and anticoagulant agents, is the cornerstone of pharmacological treatment to optimize clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Intravenous anticoagulant drugs available… read more here.
Keywords: antiplatelet; undergoing primary; antithrombotic therapy; stemi undergoing ... See more keywords
Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Interventional Cardiology"
DOI: 10.1155/2019/2750173
Abstract: Background Contrast-induced nephropathy (CIN) becomes more and more frequent after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). There have been no reported meta-analyses to determine the role of these risk… read more here.
Keywords: cin; myocardial infarction; cin patients; pci ... See more keywords
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-020-01403-6
Abstract: Background For patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI), the efficacy and safety of novel P2Y 12 antagonists, including prasugrel or ticagrelor, has not been established relative to that of… read more here.
Keywords: ticagrelor; prasugrel ticagrelor; relative clopidogrel; pci ... See more keywords